FDA-approved
Sexual & reproductive
Cetrorelix
Evidence
FDA approved
Class
GnRH antagonist
KEY TAKEAWAY
Cetrorelix is a ten-amino-acid synthetic GnRH antagonist. It is sold as Cetrotide. The FDA approved cetrorelix (Cetrotide) in 2000 for preventing premature luteinizing hormone surges in women having controlled ovarian stimulation.
Written by the Veylo editorial team · Updated
November 2026
What it is
GnRH antagonist
Approved for
Preventing early ovulation during assisted reproduction
Key fact
The FDA approved cetrorelix (Cetrotide) in 2000 for preventing premature luteinizing hormone surges in women having controlled ovarian stimulation.
Route
Daily subcutaneous injection
Evidence strength
FDA approved
Cetrorelix is a ten-amino-acid synthetic GnRH antagonist. It is sold as Cetrotide.
It blocks GnRH receptors in the pituitary gland, which prevents a premature surge of luteinizing hormone during fertility treatment.
The FDA approved cetrorelix (Cetrotide) in 2000 for preventing premature luteinizing hormone surges in women having controlled ovarian stimulation.
Preventing early ovulation during assisted reproduction.
Injection-site reactions and nausea are common. Ovarian hyperstimulation syndrome can occur during fertility treatment.
U.S. FDA prescribing information for Cetrorelix. DailyMed, National Library of Medicine.
Veylo content is educational and not medical advice. Peptides that are not FDA-approved are not approved for the uses described.